Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 3

1(20.0%)

5Total

N/A(4)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05122988Completed

Facing Adverse Childhood Experiences

Role: lead

NCT05946980Not ApplicableCompleted

hands4health: A Multi-component Intervention on Hand Hygiene in Primary Health Care Facilities in Burkina Faso and Mali

Role: collaborator

NCT06044623Phase 3Recruiting

Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients

Role: collaborator

NCT05964478Not ApplicableCompleted

Hands4Health: A Multi-component Intervention on Hand Hygiene & Well-being in Schools in Nigeria & Palestine (H4H)

Role: collaborator

NCT04637516Not ApplicableCompleted

Evaluation of an Updated Version of the Program "BlinkBlink" for Alleviation of Dry Eye Symptoms Induced by Computer Work

Role: lead

NCT03519815Not ApplicableCompleted

Clinical Study to Evaluate the Efficacy of Ectoin® Containing Eye Spray for Treatment of Dry Eye Disease

Role: lead

NCT02999035Completed

Validation of a Newly Developed Liquid Jet Aesthesiometer

Role: lead

NCT02735278Completed

Are There Different Objective Fixation Disparity Values for Two Different Test Paradigms

Role: lead

All 8 trials loaded